ENTITY

Opexa Therapeutics (OPXA US)

Health Care • United States

Acer Therapeutics Inc. operates as a pharmaceutical company. The Company develops therapies for the treatment of ultra-rare diseases, vascular ehlers-danlos syndrome, and maple syrup urine diseases. Acer Therapeutics serves patients in the United States.

Refresh

Focused

No publications yet

There aren’t any Insights right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00